The American Medical Association (AMA) is urging federal officials to uphold “known and widely accepted scientific and clinical standards for testing safety and efficacy” of botanical drug products—including cannabis, kratom and other plant-derived substances—warning that political and commercial interests should not circumvent the standard approval process. It also says a “special schedule” should be developed […]
The American Medical Association (AMA) is urging federal officials to uphold “known and widely accepted scientific and clinical standards for testing safety and efficacy” of botanical drug products—including cannabis, kratom and other plant-derived substances—warning that political and commercial interests should not circumvent the standard approval process. It also says a “special schedule” should be developed Read More CANNABIS, MARIJUANA, SOCIAL MEDIA